CERUS CORP Logo

CERUS CORP

Develops pathogen inactivation technology to reduce transfusion-transmitted infections.

CERS | US

Overview

Corporate Details

ISIN(s):
US1570851014
LEI:
Country:
United States of America
Address:
1220 CONCORD AVENUE, 94520 CONCORD

Description

Cerus Corporation is a biomedical products company dedicated to safeguarding the world's blood supply. The company develops and commercializes the INTERCEPT Blood System, a pathogen inactivation technology designed to reduce the risk of transfusion-transmitted infections. The system inactivates a broad spectrum of viruses, bacteria, parasites, and leukocytes in donated blood components. It is used for platelets and plasma, with a system for red blood cells in development. Cerus provides its technology to blood centers and hospitals, aiming to establish a new standard of care for blood safety.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-26 22:07
4
English 6.5 KB
2025-11-24 23:17 English 7.4 KB
2025-11-14 22:24 English 10.4 KB
2025-11-06 23:01
10-Q
English 2.0 MB
2025-11-06 22:03
8-K
English 218.7 KB
2025-08-25 21:25
4
English 6.4 KB
2025-08-14 22:26 English 10.4 KB
2025-08-05 23:24
S-8
English 66.1 KB
2025-08-05 22:52
10-Q
English 2.1 MB
2025-08-05 22:02
8-K
English 221.5 KB
2025-07-30 19:21 English 11.0 KB
2025-06-23 22:32
8-K
English 11.4 KB
2025-06-09 19:39
8-K
English 55.6 KB
2025-06-05 00:53
4
English 7.0 KB
2025-06-05 00:48
4
English 7.1 KB

Automate Your Workflow. Get a real-time feed of all CERUS CORP filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CERUS CORP

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CERUS CORP via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advicenne Logo
A specialty pharmaceutical company developing treatments for rare renal diseases.
France
ALDVI
AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGENUS INC Logo
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
South Korea
001540
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.